Literature DB >> 8460960

Altered brain energy metabolism in demented patients with multiple subcortical ischemic lesions. Working hypotheses.

G G Brown1, J H Garcia, J W Gdowski, S R Levine, J A Helpern.   

Abstract

We report the results of brain metabolic studies (using magnetic resonance spectroscopy) in three groups of individuals: (1) demented patients with multiple subcortical ischemic lesions (n = 18); (2) nondemented, age-matched controls (n = 21); and (3) demented patients with neurodegenerative disease, probably of the Alzheimer type (n = 19). Patients with dementia with subcortical vascular lesions, as demonstrated by appropriate imaging studies, had an increase of phosphate energy charge in areas of the cerebral cortex (especially prominent in the frontal regions) superficial to and excluded from the subcortical lesions. We hypothesize that this increased energy charge might be caused by reduced metabolic activity of disconnected brain tissue or by astrocytic hypertrophy and hyperplasia that accompanies subtle ischemic, cortical alterations.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8460960     DOI: 10.1001/archneur.1993.00540040046012

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  7 in total

Review 1.  Magnetic resonance imaging and magnetic resonance spectroscopy in dementias.

Authors:  Y Y Hsu; A T Du; N Schuff; M W Weiner
Journal:  J Geriatr Psychiatry Neurol       Date:  2001       Impact factor: 2.680

2.  Hippocampal and cortical atrophy predict dementia in subcortical ischemic vascular disease.

Authors:  G Fein; V Di Sclafani; J Tanabe; V Cardenas; M W Weiner; W J Jagust; B R Reed; D Norman; N Schuff; L Kusdra; T Greenfield; H Chui
Journal:  Neurology       Date:  2000-12-12       Impact factor: 9.910

Review 3.  The role of phospholipase A2 in neuronal homeostasis and memory formation: implications for the pathogenesis of Alzheimer's disease.

Authors:  O V Forlenza; E L Schaeffer; W F Gattaz
Journal:  J Neural Transm (Vienna)       Date:  2006-11-27       Impact factor: 3.575

4.  Reduced phospholipid breakdown in Alzheimer's brains: a 31P spectroscopy study.

Authors:  Orestes V Forlenza; Priscilla Wacker; Paula V Nunes; Juliana Yacubian; Claudio C Castro; Maria C G Otaduy; Wagner F Gattaz
Journal:  Psychopharmacology (Berl)       Date:  2005-02-08       Impact factor: 4.530

5.  Regional gray and white matter metabolite differences in subjects with AD, with subcortical ischemic vascular dementia, and elderly controls with 1H magnetic resonance spectroscopic imaging.

Authors:  S MacKay; D J Meyerhoff; J M Constans; D Norman; G Fein; M W Weiner
Journal:  Arch Neurol       Date:  1996-02

6.  The medical food Souvenaid affects brain phospholipid metabolism in mild Alzheimer's disease: results from a randomized controlled trial.

Authors:  Anne Rijpma; Marinette van der Graaf; Marieke M Lansbergen; Olga Meulenbroek; Aysun Cetinyurek-Yavuz; John W Sijben; Arend Heerschap; Marcel G M Olde Rikkert
Journal:  Alzheimers Res Ther       Date:  2017-07-26       Impact factor: 6.982

7.  Mixed-location cerebral microbleeds as a biomarker of neurodegeneration in a memory clinic population.

Authors:  Bibek Gyanwali; Muhammad Amin Shaik; Chuen Seng Tan; Henri Vrooman; Narayanaswamy Venketasubramanian; Christopher Chen; Saima Hilal
Journal:  Aging (Albany NY)       Date:  2019-11-25       Impact factor: 5.682

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.